High materiality8/10
Whitehawk Therapeutics initiated with a Buy at Stifel
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Stifel Nicolaus initiates Whitehawk Therapeutics (WHWK) with a Buy rating; target $9; current price $3.76.
Target: $9
Posted price: $3.76
Analyst firm: Stifel Nicolaus
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.